Senior Advisor and former Head of Business Development at the Wellcome Trust
Dr. Seabrook, PhD, MBA served as Head of Business Development at the Wellcome Trust, responsible for intellectual property management and its transfer, through licensing or new company formation. Seabrook also led the Technology Transfer Division, which aims to add value to basic scientific findings when they can be developed into products. This division reduces the risk, the proof of concept, and makes it attractive to follow-on investors (licensing perspective or financial community).
Director of MaRS EXCITE program at MaRS Discovery District, Health System Innovation
Khayat works to get healthcare systems to adopt the best technology to improve public health and performance, as well as promoting the new economy of health. She is also an adjunct professor in the Health Sector Strategy stream at the University of Toronto Rotman School of Management. She has 11 years of experience in strategic consulting in the healthcare and life sciences sector.
Former President and CEO of Massachussetts Life Sciences Center
A world-renowned expert in innovation, she has been called one of the "10 most influential women in biotech" by the Boston Globe and one of the "50 most powerful women in Boston" by Boston Magazine. She is managing partner at Biomedical Innovation Advisors and also President and CEO of Biomedical Growth Strategies. She has been president and CEO of the Massachusetts Life Sciences Center (MLC).
Michael Müller founded Cepton Strategies, a company that in 2014 sold the Boston's firm CRA. German financial newspaper Capital has called his company the leading strategic consultancy in healthcare, ahead of McKinsey, Boston Consulting Group and Roland Berger. Müller has led numerous projects involving private equity companies, healthcare groups and investment funds and is an expert in corporate strategy with extensive experience in business development, R&D and M&A.
Venture Partner at Draper Esprit and Chairman of the Digital Health Forum
Dr. Vishal Gulati is one of Europe's leading digital healthcare investors and a venture partner at DFJ Esprit, a firm specializing in digital health that follows the style set by Silicon Valley. He has become a renowned promoter of investment in the emerging digital health sector and presides over the Digital Health Forum. Gulati has more than a decade of experience in VC. He is on the Board of Directors at Horizon Discovery PLC and EcoEos.
David Cassak is an expert in the medical device industry, with more than 30 years of experience in the healthcare sector. He has also written extensively on medical devices. Formerly VP of Content for Elsevier Business Intelligence (EBI), publishers for the medical device and pharma industries, Cassak launched a new company two years ago with partner Steve Levin called Innovation in Medtech LLC, which publishes The MedTech Strategist, a publication focused on the global medical device industry.